Feedback / Questions
AU-007 - Aulos Biosci
https://www.businesswire.com/news/home/20241009422959/en/Aulos-Bioscience-Announces-Presentation-Detailing-Phase-2-Dose-Selection-for-AU-007-in-Solid-Tumor-Treatment-at-36th-EORTC-NCI-AACR-Symposium-on-Molecular-Targets-and-Cancer-Therapeutics
Oct 9, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next